PharmEasy acquires Medlife to become India’s largest online pharmacy

By Nikita Chaurasia  Date: 2021-05-27

PharmEasy acquires Medlife to become India’s largest online pharmacy

API Holdings Private Limited-owned PharmEasy has reportedly acquired Medlife International for an undisclosed amount. The move allowed PharmEasy to emerge as the largest player in the Indian online pharmacy sector with the combined entity likely to serve over 2 million users per month.

The deal has valued the Medlife shareholders' stake at USD 250 million, cited sources aware of the development. It appears that this acquisition marks the end of Medlife as a brand with a belief that a unified platform will better cater to consumer needs.

The Medlife users would be required to log on to the PharmEasy platform using the same credentials. However, only one-year-old data will be retained.

Dhaval Shah, the founder of PharmEasy, was quoted saying that the firm has succeeded in providing affordable healthcare to several users by establishing its presence in every locality across India.

Meanwhile, Rehan Yar Khan, the Managing Partner of Orios Ventures Partners which also is an investor in PharmEasy, stated that the combined entity will capture around 60-70% market share. This deal is expected to benefit the consumers as well as the business, he added.

It is worth noting here that PharmEasy recently reached USD 1.5 billion valuation after raising USD 323 million from API Holdings, TPG Growth, and Prosus Ventures.

If market speculations are right, the Indian e-health market is likely to reach a valuation of USD 16 billion by the year 2025, considering the fact that several leading companies including Reliance, Amazon, and Tata have been headways into this business space.

The COVID-19 pandemic has significantly changed the scenario of the e-pharma sector, with most of the population opting for online platforms to obtain general medicines and medical equipment namely thermometers, oximeters, and many more.

Moreover, the second wave of the pandemic has also allowed online pharmacies to witness a 60% increase in sales figures, experts claimed.

Source credits –

https://www.business-standard.com/article/technology/pharmeasy-buys-medlife-becomes-largest-e-pharma-firm-with-2-mn-customers-121052501055_1.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Netflix confirms producing fictionalized version of Spotify’s ascension

Netflix confirms producing fictionalized version of Spotify’s ascension

By Nikita Chaurasia

Over-the-top content streaming & production giant Netflix Inc. is reportedly working on an untitled series that tells the story of one of the most successful music streaming companies, Spotify Ltd. The six-part series, already listed on Netflix,...

Edtech Byju’s is now India’s highest-valued startup at USD 16.5 billion

Edtech Byju’s is now India’s highest-valued startup at USD 16.5 billion

By Nikita Chaurasia

Byju’s, the largest education technology company, has emerged as India’s highest-valued startup after a USD 340 million funding round involving investors such as UBS Group, Blackstone, and Zoom founder Eric Yuan among others. Recently, B...

LiDAR maker Hesai Photonics secures USD 300 million in Series D funding

LiDAR maker Hesai Photonics secures USD 300 million in Series D funding

By Nikita Chaurasia

Hesai Photonics Technology Co. Ltd., a leading Shanghai-based LiDAR company, has reportedly secured USD 300 million in a Series D funding round which was led by GL Ventures LLC, Xiaomi Corporation, Hillhouse Capital Group, Meituan, and CPE. The roun...

Tesla terminates production of its Model S Plaid + variant indefinitely

Tesla terminates production of its Model S Plaid + variant indefinitely

By Nikita Chaurasia

CEO Elon Musk justified Model S Plaid as good enough against its successor. The Model S Plaid + was touted to be Tesla’s flagship vehicle, with a range of around 519 miles. After unveiling for the first time last year, American EV maker T...

ByHeart concludes largest U.S. clinical trial for infant food product

ByHeart concludes largest U.S. clinical trial for infant food product

By Nikita Chaurasia

ByHeart Inc., a New-York based infant, and baby nutrition company, has recently announced the completion of the largest clinical trial for new infant formula in the past 25 years. With this move, the company is earmarked to be the 4th FDA registered,...